To control Covid-19 in a more effective way, leading face mask manufacturers have adopted technologies like Virus Protection Technology (VPT) approved by regulatory authorities globally to ensure maximum breathability while ensuring protection through anti-viral and anti-bacterial coating.
Alarmed with the new strain of virus post Covid-19 outbreak, Union health ministry is also in the process of evolving harmonized standard for community face coverings and is encouraging manufacturers to develop uniquely designed breath-easy mask equipped with superior technologies like VPT to ensure maximum breathability while keeping the consumer and patient protected.
The proprietary VPT technology which has been developed by leading mask manufacturer Guardwiser in India is a non-alcoholic, non-heavy metal based – food grade product. It has naturally derived ingredients sourced from coconut oil. VPT technology is a single solution for multiple problems such as bacteria, viruses, fungi and mold. The mask is stabilized in food grade aqueous solution whereas other mask coating is metal based. The technology is non-leaching, locking and bonding technology. It kills microbes by a mechanical process and not by a chemical method.
ADVANTAGE of VPT technology
- Proven to have 99.9% anti-bacterial & anti-odour efficacy even after 100 washes
- Anti-viral efficacy even after 50 washes
- N99 filter between the two fabric layers filters more than 99% of airborne particulate matter greater than 2.5 microns
- The non-leaching, locking and bonding technology and sticks to garment for up to 100 washes
- Uniqueness lies in green technology as it decomposes like oxygen, nitrogen and sand
- Does not penetrate the skin nor accumulates in the environment and does not contain carcinogenic compounds
Whereas other mask coating is metal based and erodes after a few washes. Chemical methods used in such mask to kill microbes pollute riverbeds, soil and environment. It also bio accumulates in body and environment and contains carcinogenic compounds.
N99 Breath easy mask is equipped with the revolutionary breakthrough VPT. Its ingredients are approved by USEPA, European BPR, New Zealand primary industry for the use of food contact surfaces and Therapeutic Goods Administration (TGA), Ministry of Health, Australia for the claim against corona virus.
Reference: Pharmabiz.com
In the second half of 2022, China unveiled the details of its data export regulations, providing further explanations to its existing laws and regulations on data.
The current energy crisis has reached an unsustainable level for the European chemical industry. For the first time ever, the EU imports more chemicals than it exports, both in volume and value, resulting in a trade deficit of € 5.6 bn for the first half of 2022.
Endocrine Disrupting Chemicals (also referred to as hormone disruptors or EDCs) are synthetic chemicals that are not produced by the human body and that disrupt the normal functioning of humans and animals.
The shipping industry is now returning to normality and is in a downward spiral. The cost of shipping goods from China has slumped to the lowest level in more than two years as the world economy stumbles, dimming prospects for container carriers that turned in record profits during the pandemic.
No precipitous plunge in container shipping rates, just ‘orderly’ decline.
The global food and beverage market size is expected to grow from $5.8 trillion in 2021 to $6.4 trillion in 2022 at a growth rate of 9.7%. The food and beverage market size is expected to grow to $8.9 trillion in 2026 at a compound annual growth rate of 8.7%.
The amendment makes QR codes mandatory on every active pharmaceutical ingredient. The Amendment Rules will come into force from January 01, 2023.
On June 22, 2022, the Commission adopted pioneering proposals to restore damaged ecosystems and bring nature back across Europe, from agricultural land and seas, to forests and urban environments. The Commission also proposes to reduce the use and risk of chemical pesticides by 50% by 2030.
According to New York Times, in a small clinical trial, 18 patients took a drug called Dostarlimab for around six months, and in the end, every one of them saw their tumours disappear.